Any company that aspires to prove the safety and effectiveness of a peptide will turn away from them, knowing that compounders will simply be able to sell them without ever needing to generate safety and effectiveness evidence. Indeed, Lurie continued, financial analysts are predicting a $2.2 billion telehealth marketing opportunity if these peptides are approved for compounding
Personalized hormone care that evolves with you, with ongoing provider support, flexible treatment options, and transparent pricing from the start
Among 169,649 patients with MASLD, GLP-1 receptor agonist initiation was linked to significantly lower probability of incident cirrhosis [adjusted hazard ratio (aHR): 0.86, 95%CI: 0.80-0.93], hepatic decompensation (aHR: 0.77, 95%CI: 0.65-0.90), and hepatocellular carcinoma (HCC) (aHR: 0.79, 95%CI: 0.68-0.92) over a median follow-up of 3.5 years compared to non-users
Usually, 2-4 sessions are needed for effective results
Long-term use has demonstrated sustained weight reduction, better metabolic health, and potential prevention of obesity-related complications